Stay updated on Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial
Sign up to get notified when there's something new on the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page.

Latest updates to the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page, which is a minor version change and does not affect study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedThe notice about government funding and operating status has been removed. The page now presents only the study details and related information, with no changes to the study data or eligibility criteria.SummaryDifference0.2%

- Check42 days agoChange DetectedNo significant changes detected; the study details page content appears unchanged between screenshots.SummaryDifference0.2%

- Check71 days agoChange DetectedImportant updates: added a government funding notice and current operating status for the NIH Clinical Center, and updated the version to v3.2.0 (removing v3.1.0).SummaryDifference3%

- Check78 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check93 days agoChange DetectedPage updated to revision v3.0.2, replacing v3.0.1; a 'Back to Top' link was removed as a minor UI change.SummaryDifference0.2%

Stay in the know with updates to Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page.